Based on our findings, we suggest that ADTKD-MUC1 patients not yet requiring dialysis should be treated with great caution when using HIF-stabilizing compounds as anti-anemic agents until there are more data available. Here, MUC1 is linked to autosomal dominant medullary cystic kidney disease with or without hyperuricemia.